DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020998
» See Plans and Pricing
The generic ingredient in CELEBREX is celecoxib. There are twenty-six drug master file entries for this compound. Additional details are available on the celecoxib profile page.
Summary for 020998
Tradename: | CELEBREX |
Applicant: | Gd Searle |
Ingredient: | celecoxib |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020998
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Dec 31, 1998 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Dec 31, 1998 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 400MG | ||||
Approval Date: | Aug 29, 2002 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020998
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-003 | Aug 29, 2002 | Start Trial | Start Trial |
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-004 | Dec 15, 2006 | Start Trial | Start Trial |
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-002 | Dec 31, 1998 | Start Trial | Start Trial |
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-002 | Dec 31, 1998 | Start Trial | Start Trial |
Gd Searle | CELEBREX | celecoxib | CAPSULE;ORAL | 020998-001 | Dec 31, 1998 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription